N-[(2E)-penta-2,4-dien-1-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
Structure Info
- Chemspace ID
- CSSB21331715662 (In-Stock Building Blocks)
- IUPAC Name
- N-[(2E)-penta-2,4-dien-1-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
- Mol formula
- C18H24BNO3
- Mol weight
- 313 Da
- Catalog Number(s)
- BBLS21331715662, BBV-2180336213, EN300-55399035, bbls21331715662
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 4.07
- Heavy atoms count
- 23
- Rotatable bond count
- 5
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.388
- Polar surface area (Å)
- 48
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
![Chemical structure of N-[(2E)-penta-2,4-dien-1-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide (C18H24BNO3) - CSSB21331715662](/st/structure/200/1ba2dfb6893ffc3e01952e5984b89b85/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529NC%255CC%253DC%255CC%253DC.png "C18H24BNO3")
- Zoom the structure
- CSSB21331715662
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 360.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 376.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 393.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 410.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 427.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 838.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,240.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 1,839.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of N-[(2E,4E)-hexa-2,4-dien-1-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB21331712988](/st/structure/200/95fdc733d1050f7a1999779f7594137a/C%255CC%253DC%255CC%253DC%255CCNC%2528%253DO%2529C1%253DCC%2528%253DCC%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of N-[(3E)-hexa-3,5-dien-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB21331712989](/st/structure/200/f7378dcb941511cd77a4ea92954fbf49/CC%2528NC%2528%253DO%2529C1%253DCC%2528%253DCC%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529%255CC%253DC%255CC%253DC.png)
![Chemical structure of N-[(3E)-hexa-3,5-dien-2-yl]-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB21331713779](/st/structure/200/a6ba8bc62a073f9f5dd8d5396015cb0e/CC%2528NC%2528%253DO%2529C1%253DC%2528C%2529C%253DCC%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529%255CC%253DC%255CC%253DC.png)
![Chemical structure of N-[(3E)-hexa-3,5-dien-2-yl]-4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB21331714009](/st/structure/200/960387caff8d028a800f5b844488db8c/CC%2528NC%2528%253DO%2529C1%253DCC%2528B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529%253DC%2528C%2529C%253DC1%2529%255CC%253DC%255CC%253DC.png)
![Chemical structure of N-[(2E,4E)-hexa-2,4-dien-1-yl]-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB21331713778](/st/structure/200/b55f164a1bfa82a551a551e6510f45d4/C%255CC%253DC%255CC%253DC%255CCNC%2528%253DO%2529C1%253DC%2528C%2529C%253DCC%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of N-[(2E,4E)-hexa-2,4-dien-1-yl]-4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB21331714008](/st/structure/200/5c93f1ca562da04142e522dd07d6f69d/C%255CC%253DC%255CC%253DC%255CCNC%2528%253DO%2529C1%253DCC%2528B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529%253DC%2528C%2529C%253DC1.png)
Similarity Analogs
![Chemical structure of N-[(2E)-penta-2,4-dien-1-yl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB21331715659](/st/structure/200/d0f9903a211b3519809b0fecfc56c86a/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529NC%255CC%253DC%255CC%253DC.png)
![Chemical structure of N-[(2E)-but-2-en-1-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB02148211425](/st/structure/200/4332669072ea885d74fc4bc2eb3ca87e/C%255CC%253DC%255CCNC%2528%253DO%2529C1%253DCC%253DCC%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of N-[(2E)-hex-2-en-1-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB02195990261](/st/structure/200/48add16f13c07cc83871fa802219bdc4/CCC%255CC%253DC%255CCNC%2528%253DO%2529C1%253DCC%253DCC%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
